Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function.
Tzuberi M, Brzezinski RY, Flint N, Slieman M, Zornitzki L, Viskin D, Hemed AR, Waissengrin B, Barak R, Golomb I, Wolf I, Golan N, Topilsky Y, Banai S, Kapusta L, Laufer-Perl M.
Tzuberi M, et al. Among authors: wolf i.
Cardiooncology. 2025 Jan 8;11(1):2. doi: 10.1186/s40959-024-00297-z.
Cardiooncology. 2025.
PMID: 39780280
Free PMC article.